Lack of concordance between the F-18 fluoromisonidazole PET and the F-18 FDG PET in human glioblastoma

Clinical Nuclear Medicine

Volumn 36, Issue 12, 2011, Pages

  De Clermont, Henri ^a,b   Huchet, Aymeri ^c   Lamare, Frédéric ^a,b   Rivière, Annalisa ^b   Fernandez, Philippe ^a,b  

^a HÔPITAL PELLEGRIN   (France)

^b UMR 5287   (France)

^c HÔPITAL SAINT ANDRÉ   (France)

Author keywords

F 18 fluorodeoxyglucose; F 18 fluoromisonidazole; glioblastoma; positron emission tomography

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; HEXOKINASE; HYPOXIA INDUCIBLE FACTOR 1;

ADULT; ARTICLE; BRAIN SCINTISCANNING; CANCER RADIOTHERAPY; CANCER SCINTISCANNING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG UPTAKE; GLIOBLASTOMA; GLUCOSE METABOLISM; GRAY MATTER; HUMAN; HYPOXEMIA; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION;

FLUORODEOXYGLUCOSE F18; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MISONIDAZOLE; POSITRON-EMISSION TOMOGRAPHY;

EID: 80955136549     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182335e20     Document Type: Article

References (8)

1. Cherk MH, Foo SS, Poon AM, et al. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. J Nucl Med. 2006;47:1921-1926. (Pubitemid 47544979)
2. Gagel B, Piroth M, Pinkawa M, et al. pO polarography, contrast enhanced color duplex sonography (CDS),-18F- fluoromisonidazole and-18F- fluorodeoxyglucose positron emission tomography: Validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia? BMC Cancer. 2007;7:113.
3. Serganova I, Humm J, Ling C, et al. Tumor hypoxia imaging. Clin Cancer Res. 2006;12:5260-5264. (Pubitemid 44497235)
4. Thorwarth D, Eschmann SM, Holzner F, et al. Combined uptake of-18F-FDG and-18F-FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. Radiother Oncol. 2006;80:151-156. (Pubitemid 44301544)
5. Kosaka N, Tsuchida T, Uematsu H, et al. 18F-FDG PET of common enhancing malignant brain tumors. Am J Roentgenol. 2008;190:W365-W369. (Pubitemid 351798559)
6. Chen W, Cloughesy T, Kamdar N, et al. Imaging proliferation in brain tumors with 18F-FLT PET: Comparison with 18F-FDG. J Nucl Med. 2005;46:945-952. (Pubitemid 43733508)
7. Chen W, Silverman DH. Advances in evaluation of primary brain tumors. Semin Nucl Med. 2008;38:240-250. (Pubitemid 351726325)
8. Spence AM, Muzi M, Mankoff DA, et al. 18F-FDG PET of gliomas at delayed intervals: Improved distinction between tumor and normal gray matter. J Nucl Med. 2004;45:1653-1659. (Pubitemid 47618471)